Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Proximal Crohn's disease location associated with disease behavior and surgery

This month's American Journal of Gastroenterology examines the relationship between proximal Crohn's disease location and disease behavior and surgery.

News image

In classifying Crohn's disease location, proximal disease includes esophagogastroduodenal and jejunal disease.

Dr Mark Lazarev from Maryland, USA determined the influence of proximal disease on outcomes of behavior and need for surgery.

In addition, the team determined if there was significant clinical heterogeneity between esophagogastroduodenal and jejunal disease.

The team of doctors performed a cross-sectional query of the NIDDK Inflammatory Bowel Disease Genetics Consortium database of patients with a confirmed diagnosis of Crohn's disease and phenotyped per the Inflammatory Bowel Disease Genetics Consortium  manual.

Presence of any location, proximal location, proximal-esophagogastroduodenal, L4-jejunal, and non-location, proximal disease was compared with demographic features including age, race, ethnicity, smoking and inflammatory bowel disease  family history, diagnosis age, disease duration, clinical outcomes of inflammatory, stricturing or penetrating behavior, and Crohn's disease abdominal surgeries.

Among 2,105 patients with complete disease location data, 346 had location, proximal disease with 321 having concurrent L1-L3 disease.

Stricturing risks were ileal site, longer disease duration
American Journal of Gastroenterology

In all, 1,759 had only L1-L3 disease.

The doctors noted that proximal patients were more likely to be younger at diagnosis, non-smokers, have coexisting ileal involvement, and have stricturing disease.

The team noted that proximal-esophagogastroduodenal patients were at least twice as likely to have had ileal disease, stricturing behavior, and any or multiple abdominal surgeries.

The research team noted that proximal-jejunal patients had more stricturing behavior and multiple abdominal surgeries than non-location, proximal ileal disease patients.

The researchers showed that stricturing risks were ileal site, longer disease duration, jejunal site, and older age at diagnosis.

Multiple surgery risks were disease duration, penetrating disease, and jejunal site, with short duration from diagnosis to first surgery protective.

Dr Lazarev's team commented, "Jejunal disease is a significantly greater risk factor for stricturing disease and multiple abdominal surgeries than either esophagogastroduodenal or ileal disease."

"The Montreal site classification should be revised to include separate designations for jejunal and esophagogastroduodenal disease."

Am J Gastroenterol 2013; 108:106–112
21 January 2013

Go to top of page Email this page Email this page to a colleague

 04 March 2015

Advanced search
 04 March 2015 
Progression of Barrett's
 04 March 2015 
Multidisciplinary management of rectal cancer
 04 March 2015 
Management of IBD
 03 March 2015 
Risk of anastomotic leak after colectomy
 03 March 2015 
GI bleeding in chronic kidney disease patients on aspirin
 03 March 2015 
EPHX1 polymorphism and esophageal cancer risk
 02 March 2015 
Liver disease in patients awaiting liver transplant
 02 March 2015 
Genes and early diagnosis of IBD
 02 March 2015 
Assessment of GERD
 27 February 2015 
Obesity and weight-loss therapy
 27 February 2015 
MRE performance in staging liver fibrosis
 27 February 2015 
Bleeding in diverticulosis
 26 February 2015 
Familial colorectal cancer risk and primary cancer
 26 February 2015 
Herbal products and the liver
 26 February 2015 
Questionnaires for GERD
 25 February 2015 
Exercise and NAFLD
 25 February 2015 
IBD in Korea
 25 February 2015 
Immunosuppressive therapy and T. whipplei
 24 February 2015 
Clinical trials in pediatric IBD
 24 February 2015 
Reducing health care costs in IBD
 24 February 2015 
GI bleeding after anticoagulation interruption
 23 February 2015 
Visceral abdominal obesity and IBS
 23 February 2015 
Crohn's outcomes with infliximab
 23 February 2015 
Intestinal microbiota and celiac disease
 20 February 2015 
H. pylori eradication
 20 February 2015 
Antiviral treatment and Hep C outcomes
 20 February 2015 
C. diff testing in IBD
 19 February 2015 
Intestinal microbiota in IBS
 19 February 2015 
Peptic ulcer bleeding mortality in liver disease
 19 February 2015 
Fecal microbial transplant in active Crohn's disease
 18 February 2015 
Genetic testing and GI cancers
 18 February 2015 
Placebo analgesia in functional abdominal pain
 18 February 2015 
Successful Hep C virus therapy
 17 February 2015 
Quality measures and colonoscopist selection
 17 February 2015 
Global incidence of esophageal cancer
 17 February 2015 
Anti-viral treatment and survival in Hep C
 16 February 2015 
Saliva for the diagnosis of GERD
 16 February 2015 
H pylori eradication therapy
 16 February 2015 
Medical marijuana for digestive disorders
 13 February 2015 
Prevalence of microscopic colitis
 13 February 2015 
Beta-blockers in cirrhosis
 13 February 2015 
Liver disease and peptic ulcer bleeding
 12 February 2015 
Liver disease in chronic Hep C
 12 February 2015 
Patient-reported outcomes in Hep C
 12 February 2015 
Patients’ colonoscopist selection
 11 February 2015 
Hepatic decompensation in Hep C cirrhosis
 11 February 2015 
Guidelines for the diagnosis of hepatocellular carcinoma
 11 February 2015 
NAFLD and CVD
 10 February 2015 
Percutaneous endoscopic gastrostomy
 10 February 2015 
Factors that influence hepatic steatosis
 10 February 2015 
Gene variants and Crohn's susceptibility
 09 February 2015 
Factors that influence gallstone surgery
 09 February 2015 
Factors associated with increased mortality in cirrhosis
 09 February 2015 
Use of immunomodulators in IBD
 06 February 2015 
Colorectal cancer risk in IBD
 06 February 2015 
H. pylori and peptic ulcer bleeding
 06 February 2015 
IBS and somatization
 05 February 2015 
GERD, dyspepsia and IBS symptoms
 05 February 2015 
Thalidomide and refractory Crohn's
 05 February 2015 
Quality of life in Crohn's after antitumor necrosis factor agents

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us